Lexeo Therapeutics, Inc. - Special Call

PresentationI would now like to turn the conference over to Louis Tamayo, Chief Financial Officer of Lexeo Therapeutics. Louis, please go ahead.Good morning, and welcome to the Lexeo Therapeutics webcast presentation on LX2006 for the treatment of Friedreich's ataxia cardiomyopathy. As a reminder, this call is being recorded today, October 7, 2025.Louis TamayoCFO & Principal Accounting Officer Earlier today, we released the regulatory update on our discussions to date with the FDA regarding a potential acce ...